lf_num	auroc	aupr	bce_loss	sampled_lf_name	label_source	data_source	model	epochs	l2_param	lr_param
1	0.7033712121212121	0.24603861575307884	1.1676536798477173	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_GENE_RECEIVERS	ALL	abstract	tune	500	1.2575	0.01
1	0.6955374875868917	0.3143879103128289	1.0144637823104858	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_GENE_RECEIVERS	ALL	abstract	test	500	1.2575	0.01
1	0.6730871212121213	0.23059718739157872	1.1205378770828247	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_PROGRESSION	ALL	abstract	tune	500	1.2575	0.01
1	0.6625496524329691	0.2903502074308523	0.933917760848999	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_PROGRESSION	ALL	abstract	test	500	1.2575	0.01
1	0.699564393939394	0.20152052516975535	1.2393664121627808	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_IN_SERIES	ALL	abstract	tune	500	2.505	0.01
1	0.677817775571003	0.3168346383557138	1.078811764717102	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_IN_SERIES	ALL	abstract	test	500	2.505	0.01
1	0.6739583333333334	0.1891600910301653	1.1035809516906738	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_DISTANCE_LONG	ALL	abstract	tune	500	1.2575	0.01
1	0.6648771102284011	0.3059990363220661	0.9196694493293762	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_DISTANCE_LONG	ALL	abstract	test	500	1.2575	0.01
1	0.6931060606060605	0.22884960622155381	1.1254055500030518	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GG_BICLUSTER_BINDING	ALL	abstract	tune	500	1.2575	0.01
1	0.6810917328699106	0.29804187541184	0.943943440914154	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GG_BICLUSTER_BINDING	ALL	abstract	test	500	1.2575	0.01
1	0.6905871212121212	0.19466262105539608	8.550485610961914	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER	ALL	abstract	tune	500	0.01	0.01
1	0.6724335898709037	0.3109303520854939	5.67812442779541	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER	ALL	abstract	test	500	0.01	0.01
1	0.675189393939394	0.19065245747332338	1.1026978492736816	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GiG_DOWNREGULATES	ALL	abstract	tune	500	1.2575	0.01
1	0.6660253227408143	0.3061488290413303	0.9255490899085999	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GiG_DOWNREGULATES	ALL	abstract	test	500	1.2575	0.01
1	0.6668750000000001	0.2228234139134323	8.551724433898926	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_DRUG_TARGETS	ALL	abstract	tune	500	0.01	0.01
1	0.6617738331678251	0.29470381910452936	5.679084777832031	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_DRUG_TARGETS	ALL	abstract	test	500	0.01	0.01
1	0.6732386363636365	0.1898037853219509	1.1141257286071777	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_BICLUSTER_ANTAGONISM	ALL	abstract	tune	500	1.2575	0.01
1	0.663728897715988	0.3058504419445561	0.9264078140258789	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_BICLUSTER_ANTAGONISM	ALL	abstract	test	500	1.2575	0.01
1	0.6734848484848486	0.18910999082976448	1.1127095222473145	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_DISTANCE_LONG	ALL	abstract	tune	500	1.2575	0.01
1	0.6643030039721947	0.3059245902411492	0.9261206388473511	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_DISTANCE_LONG	ALL	abstract	test	500	1.2575	0.01
1	0.6523863636363636	0.20748923734671554	1.2581381797790527	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE	ALL	abstract	tune	500	1.2575	0.01
1	0.6409353277060577	0.29639449187186495	1.0016309022903442	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE	ALL	abstract	test	500	1.2575	0.01
1	0.6725000000000001	0.2155567861877235	1.1461570262908936	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_OVEREXPRESSION	ALL	abstract	tune	500	1.2575	0.01
1	0.6561103525322741	0.2677348978097684	0.9639357924461365	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_OVEREXPRESSION	ALL	abstract	test	500	1.2575	0.01
1	0.6725378787878789	0.18844417640556083	1.1138601303100586	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CtD_WEAKLY_TREATS	ALL	abstract	tune	500	1.2575	0.01
1	0.6643340367428002	0.3023389820485918	0.9325373768806458	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CtD_WEAKLY_TREATS	ALL	abstract	test	500	1.2575	0.01
1	0.6734848484848486	0.18910999082976448	1.1128737926483154	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION	ALL	abstract	tune	500	1.2575	0.01
1	0.6620065789473684	0.3042280047132757	0.92779141664505	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION	ALL	abstract	test	500	1.2575	0.01
1	0.6734848484848486	0.18910999082976448	1.1128710508346558	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_CHECK_DEPRESSION_USAGE	ALL	abstract	tune	500	1.2575	0.01
1	0.663728897715988	0.3058504419445561	0.9264064431190491	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_CHECK_DEPRESSION_USAGE	ALL	abstract	test	500	1.2575	0.01
1	0.6790530303030303	0.2504811975040808	8.552294731140137	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	0.01	0.01
1	0.6795245779543199	0.32976019971624204	5.678849220275879	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	0.01	0.01
1	0.684185606060606	0.20695198678840337	0.6476102471351624	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_DISTANCE_SHORT	ALL	abstract	tune	500	1.2575	0.01
1	0.6531777557100298	0.2724484054055363	0.6767278909683228	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_DISTANCE_SHORT	ALL	abstract	test	500	1.2575	0.01
1	0.6678030303030305	0.18536635501065699	1.1182656288146973	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_BICLUSTER_BIOMARKERS	ALL	abstract	tune	500	1.2575	0.01
1	0.6613859235352532	0.30201917135606315	0.9383916258811951	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_BICLUSTER_BIOMARKERS	ALL	abstract	test	500	1.2575	0.01
1	0.6866666666666668	0.1901261171346913	8.548733711242676	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_BICLUSTER_INHIBITS	ALL	abstract	tune	500	0.01	0.01
1	0.6691285998013903	0.31160727255988296	5.676524639129639	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_BICLUSTER_INHIBITS	ALL	abstract	test	500	0.01	0.01
1	0.6559659090909091	0.20576421700422437	1.2730149030685425	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_BICLUSTER_TREATMENT	ALL	abstract	tune	500	1.2575	0.01
1	0.632106504468719	0.2841686587652337	1.057875394821167	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_BICLUSTER_TREATMENT	ALL	abstract	test	500	1.2575	0.01
1	0.6446401515151515	0.18172621475993012	1.2238166332244873	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_CONCLUSION	ALL	abstract	tune	500	1.2575	0.01
1	0.6495934707050645	0.2930775519768021	0.992588460445404	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_CONCLUSION	ALL	abstract	test	500	1.2575	0.01
1	0.6807765151515153	0.1917954621350064	1.0889192819595337	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_NO_VERB	ALL	abstract	tune	500	1.2575	0.01
1	0.6708819513406157	0.3049862322010749	0.9167501926422119	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_NO_VERB	ALL	abstract	test	500	1.2575	0.01
1	0.6734848484848486	0.18910999082976448	1.6933587789535522	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CtD_CONCLUSION	ALL	abstract	tune	500	1.2575	0.01
1	0.663728897715988	0.3058504419445561	1.4115971326828003	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CtD_CONCLUSION	ALL	abstract	test	500	1.2575	0.01
1	0.6734848484848486	0.18910999082976448	1.1128709316253662	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GiG_DIAGNOSIS_IDENTIFIERS	ALL	abstract	tune	500	1.2575	0.01
1	0.663728897715988	0.3058504419445561	0.9264063239097595	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GiG_DIAGNOSIS_IDENTIFIERS	ALL	abstract	test	500	1.2575	0.01
1	0.6767992424242426	0.19048913620125257	1.0997565984725952	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GiG_GENE_ADJECTIVE	ALL	abstract	tune	500	1.2575	0.01
1	0.6558000248262165	0.30607657052912485	0.9256917834281921	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GiG_GENE_ADJECTIVE	ALL	abstract	test	500	1.2575	0.01
1	0.6739015151515151	0.23782781531658714	1.1236525774002075	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_BIOMARKERS	ALL	abstract	tune	500	1.2575	0.01
1	0.6608738828202582	0.287428647158609	0.940100908279419	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_BIOMARKERS	ALL	abstract	test	500	1.2575	0.01
1	0.6734848484848486	0.18910999082976448	1.1128712892532349	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_CONCLUSION_TITLE	ALL	abstract	tune	500	1.2575	0.01
1	0.663728897715988	0.3058504419445561	0.9264064431190491	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_CONCLUSION_TITLE	ALL	abstract	test	500	1.2575	0.01
1	0.6523863636363636	0.20748923734671554	1.2581381797790527	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE	ALL	abstract	tune	500	1.2575	0.01
1	0.6409353277060577	0.29639449187186495	1.0016309022903442	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE	ALL	abstract	test	500	1.2575	0.01
1	0.6523863636363636	0.20748923734671554	1.2581381797790527	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE	ALL	abstract	tune	500	1.2575	0.01
1	0.6409353277060577	0.29639449187186495	1.0016309022903442	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE	ALL	abstract	test	500	1.2575	0.01
1	0.6931060606060605	0.22884960622155381	1.1254055500030518	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GG_BICLUSTER_BINDING	ALL	abstract	tune	500	1.2575	0.01
1	0.6810917328699106	0.29804187541184	0.943943440914154	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GG_BICLUSTER_BINDING	ALL	abstract	test	500	1.2575	0.01
1	0.6663825757575758	0.18359859852658328	1.1428589820861816	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_BICLUSTER_PREVENTS	ALL	abstract	tune	500	1.2575	0.01
1	0.6522002234359484	0.2896202922430271	0.9718847274780273	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_BICLUSTER_PREVENTS	ALL	abstract	test	500	1.2575	0.01
1	0.6734848484848486	0.18910999082976448	1.1128712892532349	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_CONCLUSION_TITLE	ALL	abstract	tune	500	1.2575	0.01
1	0.663728897715988	0.3058504419445561	0.9264064431190491	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_CONCLUSION_TITLE	ALL	abstract	test	500	1.2575	0.01
1	0.6855113636363636	0.20466116938175763	0.6973940134048462	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GG_DISTANCE_SHORT	ALL	abstract	tune	500	1.2575	0.01
1	0.6450006206554122	0.2667997585705646	0.7179579734802246	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GG_DISTANCE_SHORT	ALL	abstract	test	500	1.2575	0.01
1	0.6734848484848486	0.18910999082976448	1.1128710508346558	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_CHECK_DEPRESSION_USAGE	ALL	abstract	tune	500	1.2575	0.01
1	0.663728897715988	0.3058504419445561	0.9264064431190491	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_CHECK_DEPRESSION_USAGE	ALL	abstract	test	500	1.2575	0.01
1	0.6879545454545455	0.2626797937071841	1.1335468292236328	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_BICLUSTER_AFF_EXPRESSION	ALL	abstract	tune	500	1.2575	0.01
1	0.6628134309831182	0.3126156865098207	0.9524747133255005	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_BICLUSTER_AFF_EXPRESSION	ALL	abstract	test	500	1.2575	0.01
1	0.6484280303030303	0.18004543634527687	1.2324470281600952	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION	ALL	abstract	tune	500	1.2575	0.01
1	0.6339995034756702	0.28791935308678757	1.0042787790298462	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION	ALL	abstract	test	500	1.2575	0.01
1	0.6791666666666666	0.1897948073856084	1.0679423809051514	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_TITLE	ALL	abstract	tune	500	1.2575	0.01
1	0.6653891509433962	0.30560412662319236	0.8941559791564941	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_TITLE	ALL	abstract	test	500	1.2575	0.01
1	0.6743371212121213	0.18853944925592198	8.550248146057129	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CtD_COMPOUND_INDICATION	ALL	abstract	tune	500	0.01	0.01
1	0.6652029543197616	0.3116065872121516	5.677623271942139	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CtD_COMPOUND_INDICATION	ALL	abstract	test	500	0.01	0.01
1	0.6688068181818182	0.1876180850048564	1.1077616214752197	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GiG_UPREGULATES	ALL	abstract	tune	500	1.2575	0.01
1	0.6614479890764646	0.3048484615709933	0.9300759434700012	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_GiG_UPREGULATES	ALL	abstract	test	500	1.2575	0.01
1	0.6739583333333334	0.1891600910301653	1.1035809516906738	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_DISTANCE_LONG	ALL	abstract	tune	500	1.2575	0.01
1	0.6648771102284011	0.3059990363220661	0.9196694493293762	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_DISTANCE_LONG	ALL	abstract	test	500	1.2575	0.01
1	0.6696969696969697	0.18654982697927808	1.1164315938949585	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_BICLUSTER_INC_EXPRESSION	ALL	abstract	tune	500	1.2575	0.01
1	0.6609049155908638	0.30165277777777777	0.9332980513572693	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CG_BICLUSTER_INC_EXPRESSION	ALL	abstract	test	500	1.2575	0.01
1	0.6739015151515151	0.23782781531658714	1.1236525774002075	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_BIOMARKERS	ALL	abstract	tune	500	1.2575	0.01
1	0.6608738828202582	0.287428647158609	0.940100908279419	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_BIOMARKERS	ALL	abstract	test	500	1.2575	0.01
1	0.6905871212121212	0.19466262105539608	8.550485610961914	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER	ALL	abstract	tune	500	0.01	0.01
1	0.6724335898709037	0.3109303520854939	5.67812442779541	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER	ALL	abstract	test	500	0.01	0.01
1	0.6739015151515151	0.23782781531658714	1.1236525774002075	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_BIOMARKERS	ALL	abstract	tune	500	1.2575	0.01
1	0.6608738828202582	0.287428647158609	0.940100908279419	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_BIOMARKERS	ALL	abstract	test	500	1.2575	0.01
1	0.6699242424242425	0.18561123175540886	1.1232380867004395	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_BICLUSTER_DISEASE_ROLE	ALL	abstract	tune	500	1.2575	0.01
1	0.6590739821251241	0.31961291292612803	0.9426259398460388	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_BICLUSTER_DISEASE_ROLE	ALL	abstract	test	500	1.2575	0.01
1	0.6760227272727274	0.24002589530144183	1.1224608421325684	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_THERAPEUTIC	ALL	abstract	tune	500	1.2575	0.01
1	0.6621307100297914	0.28325827440270995	0.9419981837272644	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_THERAPEUTIC	ALL	abstract	test	500	1.2575	0.01
1	0.6571401515151515	0.21489847362832626	1.2415813207626343	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_CASUAL_MUTATIONS	ALL	abstract	tune	500	1.2575	0.01
1	0.6567465243296922	0.2929038676594127	1.0053493976593018	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_CASUAL_MUTATIONS	ALL	abstract	test	500	1.2575	0.01
1	0.6678030303030305	0.18536635501065699	1.1182656288146973	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_BICLUSTER_BIOMARKERS	ALL	abstract	tune	500	1.2575	0.01
1	0.6613859235352532	0.30201917135606315	0.9383916258811951	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_BICLUSTER_BIOMARKERS	ALL	abstract	test	500	1.2575	0.01
1	0.6663825757575758	0.18359859852658328	1.1428589820861816	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_BICLUSTER_PREVENTS	ALL	abstract	tune	500	1.2575	0.01
1	0.6522002234359484	0.2896202922430271	0.9718847274780273	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_CD_BICLUSTER_PREVENTS	ALL	abstract	test	500	1.2575	0.01
1	0.6730871212121213	0.23059718739157872	1.1205378770828247	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_PROGRESSION	ALL	abstract	tune	500	1.2575	0.01
1	0.6625496524329691	0.2903502074308523	0.933917760848999	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_BICLUSTER_PROGRESSION	ALL	abstract	test	500	1.2575	0.01
33	0.7585227272727273	0.2861350057956632	0.7331406474113464	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_PATIENT_WITH,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	3.7525	0.01
33	0.7008596077457794	0.2558859006416059	1.0967777967453003	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_PATIENT_WITH,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	3.7525	0.01
33	0.656155303030303	0.1917717214221185	1.059167504310608	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_NO_CONCLUSION,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	tune	500	5.0	0.01
33	0.6067527308838133	0.20986152805135694	1.4526004791259766	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_NO_CONCLUSION,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	test	500	5.0	0.01
33	0.7675378787878788	0.28557626923886126	5.46138334274292	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_CONCLUSION,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	tune	500	5.0	0.01
33	0.7211084905660377	0.28725505224792747	6.099954128265381	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_CONCLUSION,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	test	500	5.0	0.01
33	0.5964962121212122	0.14820707994426013	2.6966934204101562	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_WEAK_BINDING,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	tune	500	2.505	0.01
33	0.5846418818272096	0.19313051679428306	2.2350687980651855	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_WEAK_BINDING,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	test	500	2.505	0.01
33	0.710625	0.21326048447044033	1.5058494806289673	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_DISTANCE_SHORT,LF_CD_BICLUSTER_PREVENTS,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	tune	500	5.0	0.01
33	0.6662425521350547	0.25776851158700276	2.082796335220337	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_DISTANCE_SHORT,LF_CD_BICLUSTER_PREVENTS,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	test	500	5.0	0.01
33	0.6942424242424242	0.22199924215444497	3.2306418418884277	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DG_METHOD_DESC,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_TITLE,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_CONCLUSION,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_DOWNREGULATES,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	2.505	0.01
33	0.6404698361469712	0.23930750139569812	2.9581706523895264	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DG_METHOD_DESC,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_TITLE,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_CONCLUSION,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_DOWNREGULATES,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	2.505	0.01
33	0.7463068181818182	0.28668177539154077	0.609179675579071	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DG_DIAGNOSIS,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_CONCLUSION,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	3.7525	0.01
33	0.7272064299900695	0.31043189150867584	0.8189370036125183	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DG_DIAGNOSIS,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_CONCLUSION,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	3.7525	0.01
33	0.704469696969697	0.21782205003987248	1.0033761262893677	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_COMPOUND_INDICATION,LF_CD_METHOD_DESC,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	3.7525	0.01
33	0.6623013902681231	0.2426695305255785	1.3648064136505127	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_COMPOUND_INDICATION,LF_CD_METHOD_DESC,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	3.7525	0.01
33	0.6639962121212121	0.19806923969627188	2.201388359069824	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_CELLULAR_ACTIVITY,LF_DG_TITLE,LF_DG_CONCLUSION_TITLE,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_REGULATION,LF_CtD_WEAKLY_TREATS,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	tune	500	3.7525	0.01
33	0.6464436444885799	0.24310839346613744	2.477334976196289	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_CELLULAR_ACTIVITY,LF_DG_TITLE,LF_DG_CONCLUSION_TITLE,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_REGULATION,LF_CtD_WEAKLY_TREATS,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	test	500	3.7525	0.01
33	0.7228219696969697	0.24418503883855194	1.0070774555206299	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_POLYMORPHISMS,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
33	0.7012475173783516	0.2570522753407791	1.4542511701583862	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_POLYMORPHISMS,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
33	0.6741098484848485	0.18294932040482856	0.5794838070869446	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_PARENTHESIS,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	tune	500	2.505	0.01
33	0.6505089374379344	0.23971345524225324	0.7023018002510071	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_PARENTHESIS,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	test	500	2.505	0.01
33	0.7514583333333333	0.264755224223977	8.092348098754883	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_BICLUSTER_PREVENTS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_BICLUSTER_AGONISM,LF_GiG_REGULATION,LF_GiG_GENE_ADJECTIVE,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	tune	500	0.01	0.01
33	0.7223963505461768	0.31442490973041093	12.270573616027832	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_BICLUSTER_PREVENTS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_BICLUSTER_AGONISM,LF_GiG_REGULATION,LF_GiG_GENE_ADJECTIVE,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	test	500	0.01	0.01
33	0.6940909090909091	0.1934459409893009	1.5357787609100342	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_NO_VERB,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING	ALL	abstract	tune	500	5.0	0.01
33	0.6468005213505462	0.219125678951484	2.4802308082580566	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_NO_VERB,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING	ALL	abstract	test	500	5.0	0.01
33	0.583844696969697	0.15069701207491873	1.6645914316177368	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DaG_NO_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_BINDING,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_REGULATION,LF_GiG_METHOD_DESC,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	tune	500	5.0	0.01
33	0.5681789970208541	0.1881459563853502	2.5794811248779297	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DaG_NO_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_BINDING,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_REGULATION,LF_GiG_METHOD_DESC,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	test	500	5.0	0.01
33	0.7008522727272727	0.22065410423543533	4.200385093688965	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_METHOD_DESC,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_ACTIVATES	ALL	abstract	tune	500	3.7525	0.01
33	0.6825192403177756	0.2612151286597812	5.304238319396973	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_METHOD_DESC,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_ACTIVATES	ALL	abstract	test	500	3.7525	0.01
33	0.5831628787878788	0.15273089047699467	0.6275468468666077	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_BINDING,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_NO_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	1.2575	0.01
33	0.5950533763654419	0.19860612949214657	0.7556577920913696	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_BINDING,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_NO_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	1.2575	0.01
33	0.7020454545454545	0.24484214865598852	1.133293628692627	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_NO_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_PROGRESSION,LF_CtD_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CG_WEAK_BINDING,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
33	0.6733025074478649	0.260813442675037	1.7024410963058472	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_NO_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_PROGRESSION,LF_CtD_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CG_WEAK_BINDING,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
33	0.6890909090909091	0.22482571187409878	2.5819931030273438	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_DIAGNOSIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_REGULATION,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	tune	500	3.7525	0.01
33	0.7038077209533267	0.28240259919203115	3.0221714973449707	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_DIAGNOSIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_REGULATION,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	test	500	3.7525	0.01
33	0.693125	0.2507263892232841	1.3587301969528198	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_METHOD_DESC,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_NO_CONCLUSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
33	0.7137382075471698	0.2862105458942574	1.7009224891662598	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_METHOD_DESC,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_NO_CONCLUSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
33	0.6975946969696969	0.2137049480091014	1.099694013595581	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_CELLULAR_ACTIVITY,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_INCORRECT_COMPOUND,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_DISTANCE_SHORT,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
33	0.6198020109235352	0.21777106537977048	2.321794271469116	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_CELLULAR_ACTIVITY,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_INCORRECT_COMPOUND,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_DISTANCE_SHORT,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
33	0.6226515151515151	0.16886105779111552	0.6755232214927673	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DG_GENETIC_ABNORMALITIES,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	1.2575	0.01
33	0.6116093594836146	0.21185658664668336	0.7123457789421082	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DG_GENETIC_ABNORMALITIES,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	1.2575	0.01
33	0.6897348484848486	0.213088178071778	0.46632856130599976	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_BICLUSTER_PREVENTS,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	tune	500	1.2575	0.01
33	0.6496245034756702	0.23217037018843137	0.5704973340034485	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_BICLUSTER_PREVENTS,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	test	500	1.2575	0.01
33	0.6537310606060607	0.31721419002767365	23.2314453125	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DaG_CONCLUSION,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_INCORRECT_COMPOUND,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_ANTIBODY,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	tune	500	0.01	0.01
33	0.6074199354518371	0.23976742370277204	19.43687629699707	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DaG_CONCLUSION,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_INCORRECT_COMPOUND,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_ANTIBODY,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	test	500	0.01	0.01
33	0.7502462121212121	0.2887949775996375	0.5702033638954163	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_GENETIC_ABNORMALITIES,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_DISTANCE_SHORT,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	tune	500	1.2575	0.01
33	0.6910222194637538	0.2642233456607862	0.6583936810493469	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_GENETIC_ABNORMALITIES,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_DISTANCE_SHORT,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	test	500	1.2575	0.01
33	0.7384659090909091	0.31280475510121586	1.1182794570922852	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_CONCLUSION_TITLE,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_IN_SERIES,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GG_NO_VERB,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
33	0.6724025571002978	0.2629130760370101	1.7636454105377197	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_CONCLUSION_TITLE,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_IN_SERIES,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GG_NO_VERB,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
33	0.6729545454545455	0.21312276240082897	0.4326932430267334	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	1.2575	0.01
33	0.6465832919563059	0.24115708213197634	0.5218057632446289	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	1.2575	0.01
33	0.7822916666666666	0.28767434544048276	8.675418853759766	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_NO_VERB,LF_DG_BICLUSTER_BIOMARKERS,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_METHOD_DESC,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	0.01	0.01
33	0.7477346077457796	0.36002049679063375	5.806659698486328	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_NO_VERB,LF_DG_BICLUSTER_BIOMARKERS,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_METHOD_DESC,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	0.01	0.01
33	0.6955492424242424	0.2164293776914855	1.4045405387878418	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GG_IN_SERIES	ALL	abstract	tune	500	0.01	0.01
33	0.6345115441906654	0.22219453495825234	1.6789774894714355	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GG_IN_SERIES	ALL	abstract	test	500	0.01	0.01
33	0.6914772727272728	0.21801424921071594	3.1724302768707275	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_PREVENTS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	tune	500	1.2575	0.01
33	0.6329133565044687	0.2316013892878784	2.7313289642333984	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_PREVENTS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	test	500	1.2575	0.01
33	0.6593939393939394	0.2010941375817828	4.727750301361084	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
33	0.6320599553128103	0.24364512660431203	4.58743143081665	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
33	0.7027651515151514	0.2318715224732509	1.9729175567626953	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_POLYMORPHISMS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_NO_VERB,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	tune	500	5.0	0.01
33	0.6821468470705064	0.2571879698675514	2.958076238632202	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_POLYMORPHISMS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_NO_VERB,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	test	500	5.0	0.01
33	0.7194886363636364	0.23241089762857325	0.9155806303024292	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DG_TITLE,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	tune	500	3.7525	0.01
33	0.6869258937437934	0.2871425928388677	1.4746876955032349	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DG_TITLE,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	test	500	3.7525	0.01
33	0.7260606060606061	0.2559436008846532	0.9679135084152222	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE	ALL	abstract	tune	500	5.0	0.01
33	0.6976166832174776	0.254340971239731	1.365273118019104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE	ALL	abstract	test	500	5.0	0.01
33	0.7898674242424242	0.3056223181331119	0.6004650592803955	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_CELLULAR_ACTIVITY,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_NO_VERB,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_METHOD_DESC,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	tune	500	1.2575	0.01
33	0.7345611966236345	0.3183011925189132	0.7448530793190002	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_CELLULAR_ACTIVITY,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_NO_VERB,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_METHOD_DESC,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	test	500	1.2575	0.01
33	0.7595643939393939	0.33273035075432644	0.9914382696151733	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_BIOMARKERS,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
33	0.726771971201589	0.27886285069020084	1.36574125289917	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_BIOMARKERS,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
33	0.6309848484848484	0.1611062806306413	4.056591033935547	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_DOWNREGULATES,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
33	0.5824851042701092	0.1918359654260774	6.047370433807373	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_DOWNREGULATES,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
33	0.6740719696969697	0.19549311949066614	0.621180534362793	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_WEAKLY_TREATS,LF_CtD_TRIAL,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_NO_VERB,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	tune	500	1.2575	0.01
33	0.6362493793445879	0.23585861491837926	0.8157899379730225	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_WEAKLY_TREATS,LF_CtD_TRIAL,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_NO_VERB,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	test	500	1.2575	0.01
33	0.6892045454545455	0.22738353012359616	1.522927165031433	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_REGULATION,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES	ALL	abstract	tune	500	1.2575	0.01
33	0.6622703574975174	0.2433526947960394	1.343971848487854	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_REGULATION,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES	ALL	abstract	test	500	1.2575	0.01
33	0.713030303030303	0.28527118008273444	0.3816009759902954	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_NO_VERB,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_BIOMARKERS,LF_CtD_WEAKLY_TREATS,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_NO_VERB,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES	ALL	abstract	tune	500	1.2575	0.01
33	0.6785004965243295	0.24132919150455007	0.5228572487831116	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_NO_VERB,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_BIOMARKERS,LF_CtD_WEAKLY_TREATS,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_NO_VERB,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES	ALL	abstract	test	500	1.2575	0.01
33	0.7466098484848485	0.22428438210669602	0.7320118546485901	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_DISTANCE_SHORT,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES	ALL	abstract	tune	500	3.7525	0.01
33	0.6680269364448858	0.2369703491854505	1.1117451190948486	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_DISTANCE_SHORT,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES	ALL	abstract	test	500	3.7525	0.01
33	0.637159090909091	0.17171191691619392	0.6333943605422974	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_WEAKLY_TREATS,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_IN_SERIES,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_GENE_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	tune	500	1.2575	0.01
33	0.629779046673287	0.2185225627442408	0.6625816822052002	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_WEAKLY_TREATS,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_IN_SERIES,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_GENE_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	test	500	1.2575	0.01
33	0.7665151515151515	0.2850205223042321	0.4877609610557556	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_TITLE,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	tune	500	1.2575	0.01
33	0.7106659632571997	0.2858403841134635	0.6203131079673767	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_TITLE,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	test	500	1.2575	0.01
33	0.7435416666666667	0.2435180265557475	1.7364455461502075	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_NO_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_GENE_IDENTIFIERS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	tune	500	1.2575	0.01
33	0.713179617676266	0.2879353567052225	1.6537576913833618	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_NO_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_GENE_IDENTIFIERS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	test	500	1.2575	0.01
33	0.7612310606060605	0.2991798200465724	0.636170506477356	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_INCORRECT_COMPOUND,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_INC_EXPRESSION,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	tune	500	1.2575	0.01
33	0.7087264150943395	0.2867526982664286	0.7232397198677063	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_INCORRECT_COMPOUND,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_INC_EXPRESSION,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	test	500	1.2575	0.01
33	0.636003787878788	0.17693179601492207	0.89858478307724	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_CtD_TRIAL,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_WEAK_BINDING,LF_CG_ANTIBODY,LF_CG_NO_VERB,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_METHOD_DESC,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	3.7525	0.01
33	0.6183279543197617	0.2126727497593703	1.170526146888733	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_CtD_TRIAL,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_WEAK_BINDING,LF_CG_ANTIBODY,LF_CG_NO_VERB,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_METHOD_DESC,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	3.7525	0.01
33	0.7490530303030304	0.2619234234749567	0.6521881222724915	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_TITLE,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	3.7525	0.01
33	0.707640268123138	0.29978839408325	0.8457242250442505	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_TITLE,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	3.7525	0.01
33	0.7416666666666667	0.2806493516800571	0.3754595220088959	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CG_IN_SERIES,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_AGONISM,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	1.2575	0.01
33	0.6483831926514398	0.2531159473478214	0.5459995865821838	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CG_IN_SERIES,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_AGONISM,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	1.2575	0.01
33	0.7537689393939393	0.2716627490317569	0.742739737033844	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_CtD_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_DISTANCE_SHORT,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	3.7525	0.01
33	0.7211860724925522	0.27762347388602787	1.0025742053985596	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_CtD_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_DISTANCE_SHORT,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	3.7525	0.01
33	0.7811174242424241	0.2864541314451253	1.3018784523010254	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CtD_TRIAL,LF_CtD_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES	ALL	abstract	tune	500	3.7525	0.01
33	0.7036680734856008	0.25655762393203585	1.6489254236221313	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CtD_TRIAL,LF_CtD_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES	ALL	abstract	test	500	3.7525	0.01
33	0.8129166666666667	0.36099203394799745	0.9759182333946228	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_CtD_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	1.2575	0.01
33	0.7485569761668321	0.33726146191025586	1.0926133394241333	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_CtD_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	1.2575	0.01
65	0.697310606060606	0.1977858343273765	3.0763325691223145	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.6493917576961271	0.2195950343790956	4.240179061889648	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.6312121212121212	0.1635624337665828	2.0529491901397705	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.5935793197616683	0.19091065736970875	3.2476301193237305	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.7431060606060607	0.2564873048225221	0.8435724973678589	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	1.2575	0.01
65	0.6963443396226415	0.2612431976387225	0.9432942271232605	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	1.2575	0.01
65	0.6391477272727273	0.1594568812340642	1.236327052116394	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_NO_VERB,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
65	0.607559582919563	0.20012627419249956	1.9478024244308472	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_NO_VERB,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
65	0.6946590909090908	0.19806558624706216	2.229127883911133	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
65	0.6270481628599802	0.2137577935643511	2.5608761310577393	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
65	0.7369886363636364	0.25422895999883294	1.4731703996658325	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_TITLE,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.6668787239324726	0.2444981052322737	2.2345008850097656	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_TITLE,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.6920265151515153	0.19677422408454676	0.9924372434616089	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	3.7525	0.01
65	0.6579568023833168	0.2287943772065819	1.4266643524169922	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	3.7525	0.01
65	0.6765151515151515	0.18775045061611811	1.8853158950805664	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.6252948113207548	0.2173378727816906	2.9314796924591064	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.6678598484848486	0.18582228893278527	2.4535889625549316	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	2.505	0.01
65	0.6200657894736842	0.21123666291870224	2.3972790241241455	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	2.505	0.01
65	0.6905492424242424	0.19278083098179383	1.3469834327697754	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
65	0.6613393743793448	0.2261444979572212	2.0256903171539307	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
65	0.6834848484848484	0.19260901649746504	2.0657460689544678	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
65	0.6515330188679246	0.24101060221791062	3.044771909713745	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
65	0.7422159090909091	0.24959138292539726	0.49954497814178467	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	tune	500	1.2575	0.01
65	0.681308962264151	0.2626805332436629	0.6354568004608154	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_INCREASES_EXPRESSION	ALL	abstract	test	500	1.2575	0.01
65	0.7308143939393938	0.22517080302593578	1.8336795568466187	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING	ALL	abstract	tune	500	5.0	0.01
65	0.6838071002979146	0.24248392102645686	2.45100736618042	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING	ALL	abstract	test	500	5.0	0.01
65	0.6090530303030303	0.14998596081099308	3.1859209537506104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_METHOD_DESC,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.5618948609731876	0.17876793034183486	3.4512767791748047	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_METHOD_DESC,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.6067424242424243	0.14790286709807676	2.6943752765655518	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.6028581181727904	0.20545192787219488	4.23294734954834	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.6639204545454547	0.1863238289218049	1.6809014081954956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	3.7525	0.01
65	0.6308031281032771	0.22026622846072424	2.033013105392456	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	3.7525	0.01
65	0.6533333333333334	0.17400366909018297	4.004799842834473	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_INHIBITS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.6070630585898709	0.19908538857785246	5.526030540466309	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_INHIBITS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.6602272727272727	0.1735036037029437	1.9961867332458496	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	tune	500	5.0	0.01
65	0.6257913356504469	0.20437766824994733	2.789766788482666	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	test	500	5.0	0.01
65	0.7384848484848483	0.2563038265633001	1.4622607231140137	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_TITLE,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_NO_VERB,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.687639647467726	0.2676825042746338	2.1214537620544434	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_TITLE,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_NO_VERB,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.6668560606060605	0.17818400909089577	1.508446455001831	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.5844867179741807	0.18799165963020786	2.119157314300537	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.6475757575757576	0.1682803016017307	1.9280023574829102	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.5931603773584906	0.19782432964648375	3.2415390014648438	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.7174431818181819	0.22282720664319122	0.5231503844261169	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	1.2575	0.01
65	0.6536277308838132	0.21977460847967184	0.7065276503562927	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	1.2575	0.01
65	0.7342613636363636	0.24139432646548356	1.3298029899597168	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	1.2575	0.01
65	0.661944513406157	0.2293738020860986	1.4173388481140137	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	1.2575	0.01
65	0.7104356060606061	0.20903760581693454	2.21213698387146	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
65	0.63572182224429	0.21401340743783442	3.5955607891082764	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_NO_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
65	0.7290719696969696	0.23380851742231207	1.463354468345642	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.6826433714001987	0.2649266330256516	2.293537139892578	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.6506439393939394	0.1787662018569694	1.034816026687622	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.6281498262164846	0.20908154288630387	1.8231059312820435	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.7090719696969697	0.20406692386762587	1.4938119649887085	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	2.505	0.01
65	0.6647529791459781	0.2519573680200478	1.5890330076217651	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	2.505	0.01
65	0.7377462121212122	0.2441996629239808	1.6269642114639282	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	3.7525	0.01
65	0.6703233614697119	0.24075012502719467	2.096341609954834	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	3.7525	0.01
65	0.7224810606060605	0.2330179318149702	0.6886388659477234	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_GENE_IDENTIFIERS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	1.2575	0.01
65	0.6517657646474677	0.22953998186917268	0.8301398754119873	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_GENE_IDENTIFIERS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	1.2575	0.01
65	0.7482765151515152	0.25584241529764523	1.2310967445373535	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	1.2575	0.01
65	0.6830778301886792	0.2778465876749098	1.2274463176727295	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	1.2575	0.01
65	0.7144507575757575	0.21708157077765589	1.7261484861373901	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	tune	500	5.0	0.01
65	0.6592601787487588	0.24495164293107524	2.81508731842041	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	test	500	5.0	0.01
65	0.7101704545454545	0.20668205073331733	0.9217342138290405	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	2.505	0.01
65	0.6560482869910627	0.23989219311873652	1.1226069927215576	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	2.505	0.01
65	0.7115340909090909	0.2108090518510289	2.142031669616699	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.655598311817279	0.22735754143495143	3.290210008621216	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.7628409090909091	0.266680280133267	0.496364951133728	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	1.2575	0.01
65	0.6941720456802384	0.272717219311817	0.6792617440223694	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	1.2575	0.01
65	0.7046780303030303	0.22032672202221085	1.0677462816238403	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	3.7525	0.01
65	0.6702457795431975	0.23248590916312745	1.4180694818496704	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	3.7525	0.01
65	0.6833333333333332	0.18960598865968498	1.615576982498169	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
65	0.6169004468718967	0.19757233126596155	2.90511417388916	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
65	0.7009848484848487	0.2143511564414974	1.6308865547180176	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_NO_VERB,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
65	0.6476228897715989	0.22795106711527283	2.682689666748047	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_NO_VERB,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
65	0.5985795454545454	0.14702843118487674	3.040806770324707	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.5543383813306851	0.1682242911503642	3.04939341545105	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.7532575757575758	0.26086613737436765	2.042203664779663	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	tune	500	5.0	0.01
65	0.71293135551142	0.28740990298274105	3.419294595718384	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION	ALL	abstract	test	500	5.0	0.01
65	0.7234659090909091	0.22529336557134788	1.2837965488433838	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
65	0.6601446127110228	0.22332250459718317	2.1174755096435547	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
65	0.6624431818181817	0.18012188412192748	2.057863235473633	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
65	0.5971170556107249	0.1911762166799657	3.1864829063415527	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
65	0.6782765151515151	0.18072602312663127	1.908345341682434	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.6465212264150944	0.21396409395194183	2.284085750579834	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.7303787878787878	0.2240534856671977	1.50655198097229	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
65	0.6597567030784508	0.230960120528373	2.2511024475097656	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_NO_VERB,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
65	0.7361742424242425	0.22802884048142913	1.8528321981430054	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	tune	500	5.0	0.01
65	0.6769488579940417	0.23827762045992446	2.90560245513916	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING	ALL	abstract	test	500	5.0	0.01
65	0.6451325757575758	0.17113140058397494	0.6149829030036926	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	1.2575	0.01
65	0.6150384806355511	0.21468204470855992	0.7378979325294495	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	1.2575	0.01
65	0.7024242424242424	0.2060475929847788	1.524161696434021	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.6334719463753724	0.2183230734391809	2.6536612510681152	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.7237878787878788	0.23298552687565752	1.5059638023376465	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.6558155412115194	0.24246278819669265	2.1692798137664795	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.7092045454545454	0.21214569899959762	1.8898704051971436	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
65	0.6306634806355511	0.22460153075367473	3.06189227104187	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DG_ALLOWED_DISTANCE,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_DISTANCE_SHORT,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_CONCLUSION,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
65	0.6835795454545455	0.18643688269796738	1.991160273551941	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
65	0.6482900943396226	0.21040967053578152	2.6208221912384033	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
65	0.7808333333333335	0.2962010233156356	0.8075288534164429	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	1.2575	0.01
65	0.7106038977159881	0.27609360548946976	0.978988528251648	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	1.2575	0.01
97	0.7017234848484849	0.20216174842700924	2.237741708755493	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6394767874875869	0.2147469578187291	3.103971242904663	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6833143939393939	0.18833409439175802	2.4567816257476807	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6247362214498511	0.20386165873566073	3.524688482284546	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.686496212121212	0.18990147937473453	2.4293320178985596	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6294221698113207	0.20810497371395983	3.49401593208313	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6985795454545455	0.19652766917133074	2.236680269241333	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6404232869910624	0.21690768368083946	3.7490737438201904	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6948674242424243	0.1970086196751479	2.123178482055664	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6328357745779544	0.20939422719251546	2.891718864440918	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6753977272727272	0.18117053480268025	2.4197194576263428	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.619833043694141	0.2030088917922514	3.5347821712493896	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6840719696969697	0.18800251957662573	2.336592435836792	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6268929990069514	0.20552866710531068	3.529644012451172	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6825568181818182	0.18721612530978604	2.412208318710327	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6286153177755709	0.20866508792334257	3.511308193206787	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6848295454545454	0.18828283188925338	2.412497043609619	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.629142874875869	0.2077896821055163	3.524590492248535	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6861174242424243	0.18957186494949005	2.434265613555908	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6289566782522344	0.20798224165057125	3.494225025177002	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.687594696969697	0.1887234274647911	2.323381185531616	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6326806107249255	0.20922483979322698	3.517699718475342	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6839583333333334	0.18824513977453955	2.320279359817505	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6282739572989077	0.20835615191894521	3.507930278778076	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6840719696969697	0.1883308747150395	2.4126088619232178	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6279636295928501	0.20779587232165264	3.5281951427459717	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.674375	0.18083809217549512	2.389674425125122	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6218346573982125	0.2062264840303339	3.6631577014923096	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6942613636363635	0.19417657392426102	2.22879695892334	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6380803128103276	0.21427666894202657	3.6483876705169678	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6853977272727273	0.18938109657683466	2.4342782497406006	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6296083664349554	0.20863410542560068	3.488992691040039	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6867613636363636	0.19012893759854146	2.427987813949585	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6289256454816287	0.2079650757040126	3.4942193031311035	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6860037878787879	0.18926688929735352	2.4324522018432617	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6284291211519365	0.20761940136860846	3.4825119972229004	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6810037878787878	0.1865735965547486	2.324221611022949	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6240535004965243	0.20328140529594813	3.4447574615478516	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6839962121212121	0.18813333780249944	2.412135601043701	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.627979145978153	0.2074821254687684	3.5264384746551514	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6867992424242424	0.18903653782943006	2.3980607986450195	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.628087760675273	0.2079832702612408	3.511992931365967	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6952083333333332	0.19700568359773463	2.040928602218628	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6369321002979146	0.2141055382567742	3.0606508255004883	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6991098484848486	0.1981692350269285	2.029381036758423	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6418973435948361	0.2157414167630956	3.042712450027466	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6833901515151515	0.18720234655774445	2.4184627532958984	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6279015640516385	0.20665027137403738	3.533149480819702	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6847916666666666	0.18825176920253156	2.4129416942596436	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6289566782522343	0.20771251026603882	3.5250370502471924	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.682215909090909	0.18680003537709494	2.3265297412872314	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6268774826216486	0.20884376220836354	3.4841108322143555	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6896780303030303	0.19065617260263865	2.995239734649658	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6355045928500497	0.21306277936605053	4.833758354187012	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6985795454545456	0.19701582941233572	1.9468954801559448	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.638297542204568	0.2124658412606438	3.0599207878112793	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6828219696969696	0.18893791255153125	2.366037130355835	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.621260551142006	0.203723873176813	3.7342803478240967	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6850378787878788	0.18919815492243713	2.5077598094940186	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6270636792452831	0.207273170739505	3.5396931171417236	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6728977272727272	0.17981865386127927	2.3809633255004883	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6144643743793445	0.1992056049384445	3.544677972793579	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6913825757575758	0.1921116848772375	2.301288604736328	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6326185451837141	0.20937164522126786	3.5153846740722656	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6857007575757577	0.1889241208447292	2.412294626235962	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6284601539225422	0.20710287304846725	3.52823805809021	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6895265151515151	0.19303039417387832	2.0273072719573975	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6374906901688183	0.21440556492060114	3.0303101539611816	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6814204545454545	0.18701106784111993	2.4011683464050293	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.627839498510427	0.20830000625790082	3.5016674995422363	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6880113636363636	0.19065169172321905	2.4268980026245117	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
97	0.6326340615690169	0.2088007179741249	3.4495179653167725	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
97	0.6860227272727273	0.18817774059716985	2.4313125610351562	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6259620158887785	0.2071898171497968	3.380666971206665	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6759280303030303	0.18237539983744755	2.4981513023376465	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6192744538232372	0.20262656886836874	3.45615291595459	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6947537878787879	0.1944338394831888	2.206428289413452	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.638949230387289	0.21580028153194325	3.72383975982666	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.681344696969697	0.18647845223592546	2.321793556213379	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6307565789473684	0.2099376326618633	3.4893572330474854	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.686155303030303	0.18976190198806397	2.5092828273773193	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	tune	500	5.0	0.01
97	0.632246151936445	0.2097941352854731	3.4526045322418213	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN	ALL	abstract	test	500	5.0	0.01
97	0.6842234848484849	0.18808464996078667	2.4152474403381348	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6300117924528302	0.2075221082163627	3.523250102996826	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6934280303030304	0.19320785938190635	2.2461061477661133	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6378010178748759	0.21431417767225053	3.7501590251922607	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6853598484848484	0.18867091477632142	2.4089198112487793	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6299497269116187	0.20800376910353474	3.52476167678833	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6808901515151515	0.18652614161241915	2.324583053588867	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6240224677259186	0.20329196961591134	3.4451024532318115	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6881818181818182	0.18889411675353454	2.4257960319519043	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6267688679245284	0.2068157718759843	3.3774163722991943	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6921401515151515	0.19284425836649233	2.207197904586792	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6367769364448859	0.2153597295485638	3.61562442779541	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6964962121212122	0.19706500223388218	2.037827968597412	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6380492800397219	0.21375793655004524	3.05462646484375	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6852083333333333	0.18839172228350146	2.323770046234131	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6331150695134062	0.21049156977267441	3.500216245651245	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
97	0.6952462121212121	0.19522706979152735	2.2267394065856934	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
97	0.6391354270109235	0.21516956434843051	3.6464903354644775	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
99	0.6848295454545454	0.18828283188925338	2.41249680519104	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	tune	500	5.0	0.01
99	0.629142874875869	0.2077896821055163	3.524590253829956	LF_HETNET_HI_I_05,LF_HETNET_VENKATESAN_09,LF_HETNET_YU_11,LF_HETNET_HI_II_14,LF_HETNET_LIT_BM_13,LF_HETNET_II_BINARY,LF_HETNET_II_LITERATURE,LF_HETNET_HETIO_DAG,LF_HETNET_GiG_ABSENT,LF_DG_IS_BIOMARKER,LF_DaG_ASSOCIATION,LF_DaG_WEAK_ASSOCIATION,LF_DaG_NO_ASSOCIATION,LF_DaG_CELLULAR_ACTIVITY,LF_DaG_DISEASE_SAMPLE,LF_DG_METHOD_DESC,LF_DG_TITLE,LF_DG_GENETIC_ABNORMALITIES,LF_DG_DIAGNOSIS,LF_DG_PATIENT_WITH,LF_DG_CONCLUSION_TITLE,LF_DaG_NO_CONCLUSION,LF_DaG_CONCLUSION,LF_DG_DISTANCE_SHORT,LF_DG_DISTANCE_LONG,LF_DG_ALLOWED_DISTANCE,LF_DG_NO_VERB,LF_DG_CONTEXT_SWITCH,LF_DG_BICLUSTER_CASUAL_MUTATIONS,LF_DG_BICLUSTER_MUTATIONS,LF_DG_BICLUSTER_DRUG_TARGETS,LF_DG_BICLUSTER_PATHOGENESIS,LF_DG_BICLUSTER_THERAPEUTIC,LF_DG_BICLUSTER_POLYMORPHISMS,LF_DG_BICLUSTER_PROGRESSION,LF_DG_BICLUSTER_BIOMARKERS,LF_DG_BICLUSTER_OVEREXPRESSION,LF_DG_BICLUSTER_REGULATION,LF_CtD_TREATS,LF_CD_CHECK_DEPRESSION_USAGE,LF_CtD_WEAKLY_TREATS,LF_CD_INCORRECT_COMPOUND,LF_CtD_COMPOUND_INDICATION,LF_CtD_TRIAL,LF_CD_IN_SERIES,LF_CD_METHOD_DESC,LF_CD_TITLE,LF_CtD_NO_CONCLUSION,LF_CtD_CONCLUSION,LF_CD_DISTANCE_SHORT,LF_CD_DISTANCE_LONG,LF_CD_ALLOWED_DISTANCE,LF_CD_NO_VERB,LF_CD_BICLUSTER_TREATMENT,LF_CD_BICLUSTER_INHIBITS,LF_CD_BICLUSTER_SIDE_EFFECT,LF_CD_BICLUSTER_PREVENTS,LF_CD_BICLUSTER_ALLEVIATES,LF_CD_BICLUSTER_DISEASE_ROLE,LF_CD_BICLUSTER_BIOMARKERS,LF_CG_BINDING,LF_CG_WEAK_BINDING,LF_CG_GENE_RECEIVERS,LF_CG_ASE_SUFFIX,LF_CG_IN_SERIES,LF_CG_ANTIBODY,LF_CG_METHOD_DESC,LF_CG_NO_CONCLUSION,LF_CG_CONCLUSION,LF_CG_DISTANCE_SHORT,LF_CG_DISTANCE_LONG,LF_CG_ALLOWED_DISTANCE,LF_CG_NO_VERB,LF_CG_BICLUSTER_BINDS,LF_CG_BICLUSTER_AGONISM,LF_CG_BICLUSTER_ANTAGONISM,LF_CG_BICLUSTER_INC_EXPRESSION,LF_CG_BICLUSTER_DEC_EXPRESSION,LF_CG_BICLUSTER_AFF_EXPRESSION,LF_CG_BICLUSTER_INHIBITS,LF_GiG_BINDING_IDENTIFICATIONS,LF_GiG_CELL_IDENTIFICATIONS,LF_GiG_COMPOUND_IDENTIFICATIONS,LF_GiG_UPREGULATES,LF_GiG_DOWNREGULATES,LF_GiG_REGULATION,LF_GiG_ASSOCIATION,LF_GiG_BOUND_IDENTIFIERS,LF_GiG_GENE_IDENTIFIERS,LF_GiG_GENE_ADJECTIVE,LF_GiG_DIAGNOSIS_IDENTIFIERS,LF_GiG_METHOD_DESC,LF_GiG_PARENTHESIS,LF_GG_IN_SERIES,LF_GiG_NO_CONCLUSION,LF_GiG_CONCLUSION,LF_GG_DISTANCE_SHORT,LF_GG_DISTANCE_LONG,LF_GG_ALLOWED_DISTANCE,LF_GG_NO_VERB,LF_GG_BICLUSTER_BINDING,LF_GG_BICLUSTER_ENHANCES,LF_GG_BICLUSTER_ACTIVATES,LF_GG_BICLUSTER_AFFECTS_EXPRESSION,LF_GG_BICLUSTER_INCREASES_EXPRESSION,LF_GG_BICLUSTER_SIGNALING,LF_GG_BICLUSTER_IDENTICAL_PROTEIN,LF_GG_BICLUSTER_CELL_PRODUCTION	ALL	abstract	test	500	5.0	0.01
